Cortechs.ai | Introducing NeuroQuant MS Lesion Dynamics Computation: A Clearer Path to Understanding Disease Progression

Introducing NeuroQuant MS Lesion Dynamics Computation: A Clearer Path to Understanding Disease Progression

We’re excited to announce an update to NeuroQuant MS: a simplified and more intuitive method for analyzing lesion dynamics across multiple timepoints. With the release of version 5.0, this enhancement provides clearer insights into lesion changes, aiding in the understanding of disease progression.

The Updated NeuroQuant MS Lesion Dynamics

The NeuroQuant FLAIR module, a cornerstone of our MS solution, processes 3D T1 and T2 FLAIR images to provide information on brain lesions characterized by hyperintensities in the T2 FLAIR images using a static deep-learning model.

If earlier scans for the patient have been processed on the system, the output will now include a new series that visualizes color-coded changes in lesions over time. The updated algorithm, released in version 5.0, simplifies the way lesion dynamics are computed across two timepoints. By using segmentation masks from both the current and prior studies, the system now calculates and visualizes lesion changes, offering more intuitive data with clearer labeling and improved visualization of affected areas.

Breaking Down the Lesion Dynamics Report

The DICOM output visualizes areas of change and aligns with the updated Lesion Dynamics Table in the NeuroQuant MS report, providing key insights into lesion burden:

  • Prior lesion burden = Stable + Shrinking (Represents the sum of Stable and Shrinking lesions)
  • Current lesion burden = Stable + New + Enlarging (Represents the sum of Stable, New, and Enlarging lesions.)

A New Way to Visualize Change

The colors used in the visual output enhance the clarity of lesion change data:

  • Red: New lesions
  • Orange: Enlarging lesions
  • Green: Stable lesions
  • Blue: Shrinking lesions

Cortechs.ai | Introducing NeuroQuant MS Lesion Dynamics Computation: A Clearer Path to Understanding Disease Progression   Cortechs.ai | Introducing NeuroQuant MS Lesion Dynamics Computation: A Clearer Path to Understanding Disease Progression

Customization for Your Needs

We’ve also introduced configurable parameters for enhanced flexibility. You can now configure the minimum voxel count for thresholding absolute change and adjust percent volume change. This color-coding allows for quick identification and analysis of lesion changes over time.

This update to NeuroQuant MS provides a more straightforward and informative way to track and understand lesion dynamics, enhancing the value of NeuroQuant in clinical practice.

For more detailed information on thresholds, current customers can refer to the NeuroQuant User Manual.

More Resources

06/08/2026

Cortechs.ai and TAC Center Celebrate One Year of Advancing Neuroimaging Innovation in Peru

TAC Centers Peru is celebrating one year of integrating the NeuroQuant® suite into clinical practice.

06/04/2026

SNMMI 2026: Advancing the Future of Quantitative PET in Dementia Imaging

At SNMMI 2026, Cortechs.ai showcased NeuroQuant® PET and the growing role of quantitative PET imaging in dementia care.

06/02/2026

Cortechs.ai Collaborates with Microsoft to Bring AI-Powered Imaging Insights Directly into Radiology Workflows

Cortechs.ai and Microsoft are partnering to help bring advanced AI-powered quantitative imaging directly into radiology workflows.

05/26/2026

Cortechs.ai Partners with ARJ Medical to Advance AI-Driven Neuro and Prostate Imaging in the Middle East

Cortechs.ai and ARJ Medical have partnered to expand access to AI-powered neuro and prostate imaging solutions across the Middle East.

05/26/2026

ASNR 2026 Highlights the Growing Role of Quantitative Imaging in Neurology

ASNR 2026 brought together leaders across neuroradiology, imaging AI, and neurological care to explore the future of quantitative imaging.

05/11/2026

Better Models, Better Care: Inside Our Latest Brain Tumor Update

Explore how NeuroQuant® Brain Tumor v2.1 advances AI-powered brain tumor segmentation and clinical workflows.
Scroll to Top